Intensive Care News and Research

RSS

How 'superspreaders' impact COVID-19

A new study published on the preprint server medRxiv in May 2020 reflects the need to rethink and selectively impose lockdown on some but not all social activities, in the light of the impact of superspreaders on disease transmission.

24 May 2020

Capillary leakage important in COVID-19 respiratory distress

Now, a new study published on the preprint server medRxiv reports the pivotal role played by protein leakage through lung capillaries and promotes the use of serum albumin as a biomarker of disease progression and severity.

24 May 2020

Teens develop septic shock due to COVID-19

Since the emergence of the novel coronavirus disease (COVID-19), most people who develop severe illness are older adults, those with underlying medical conditions, and those who are immunocompromised. Though children are mostly spared, some adolescents developed septic shock due to COVID-19, a new study has found.

24 May 2020

Blanket prescription of do-not-resuscitate orders in COVID-19 patients may be unwarranted

It's inappropriate to consider blanket do-not-resuscitate orders for COVID-19 patients because adequate data is not yet available on U.S. survival rates for in-hospital resuscitation of COVID-19 patients and data from China may not relate to U.S. patients, according to a new article published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

22 May 2020

Study identifies risk factors for severe COVID-19 or death in the UK

Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.

22 May 2020

A clinical decision support system to help identify adverse health events in trauma patients

Chinese researchers from The Trauma Center of Peking University People's Hospital and National Institute of Health Data Science at Peking University are using big data to help identify trauma patients who could experience potential adverse health events in the emergency department through the aid of a clinical decision support system.

22 May 2020

Blood test could reveal how the immune system responds to coronavirus

A highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19, reveals new aspects of how the SARS-Cov-2 coronavirus causes disease.

22 May 2020

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

An estimated 70–80% of ventilated patients will experience ICU delirium, which causes patients to enter a confused state and can lead to long-term cognitive impairments and memory deficits. GlobalData, therefore, expects to see an increase in the administration of pharmacological treatments for ICU delirium as the COVID-19 outbreak continues.

22 May 2020

Panasonic team develops prototype breathing devices to help hospitalized COVID-19 patients

The team at Panasonic Manufacturing UK’s facility in Cardiff have produced 80 prototype breathing devices to assist hospital patients suffering from COVID-19.

22 May 2020

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

With many hundreds of thousands of deaths due to the current COVID-19 pandemic, there is a rush to find an effective vaccine or drug against the virus. A new study on the preprint server medRxiv* in May 2020 shows that the use of some biologically plausible drugs may be counterproductive, and care should be taken when trying out unproven therapies.

22 May 2020

RAAS inhibitors are safe to use in COVID-19 patients, study shows

The coronavirus disease (COVID-19) is a novel illness that has spread across the globe in just five months. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral infection binds to the angiotensin-converting enzyme 2 (ACE2) to enter and invade cells.

21 May 2020

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO specialized in the development and production of Advance Therapy Medicinal Products (ATMPs) and mammalian cell line-expressed biotherapeutics, today announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

21 May 2020

Does abdominal fat affect COVID-19 outcomes?

As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.

21 May 2020

Medical rationing could cause unlawful death from COVID-19

While the initial coronavirus peak is starting to pass - in Europe, at least - without the ventilator shortages many feared, the spectre of a second wave or future outbreak means questions of medical rationing still hold sway.

21 May 2020

Research looks at COVID-19 in cancer patients

As the world grapples with the COVID-19 pandemic, new questions arise as to the risk posed by the virus to different patient populations, including the elderly and those with underlying disease. A new study published on the preprint server medRxiv* in May 2020 deals with the risk of COVID-19 in the subgroup of patients with cancer.

21 May 2020

Study focuses on COVID-19 patients with inflammatory rheumatic diseases

The ongoing COVID-19 pandemic has caused nearly five million cases and over 327,000 deaths worldwide. The signs and symptoms of this disease are varied, although there are typical features which assist diagnosis.

20 May 2020

Florida Hospital implement the Babyleo TN500 IncuWarmer beds from Draeger

Florida Hospital today announced it’s the first in the United States to implement the Babyleo TN500 IncuWarmer beds from Draeger, Inc., a world leader in medical technology. With an estimated 15 million babies born preterm annually according to the World Health Organization, this technology is critically important for both babies and families. The beds are in use in Neonatal Intensive Care Units (NICU) at three hospitals across the health system in Central Florida.

From Drägerwerk AG & Co. KGaA 20 May 2020

Intensive Care News and Research

How 'superspreaders' impact COVID-19

Capillary leakage important in COVID-19 respiratory distress

Teens develop septic shock due to COVID-19

Blanket prescription of do-not-resuscitate orders in COVID-19 patients may be unwarranted

Study identifies risk factors for severe COVID-19 or death in the UK

A clinical decision support system to help identify adverse health events in trauma patients

Blood test could reveal how the immune system responds to coronavirus

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

Panasonic team develops prototype breathing devices to help hospitalized COVID-19 patients

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

RAAS inhibitors are safe to use in COVID-19 patients, study shows

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Does abdominal fat affect COVID-19 outcomes?

Medical rationing could cause unlawful death from COVID-19

Research looks at COVID-19 in cancer patients

Study focuses on COVID-19 patients with inflammatory rheumatic diseases

Florida Hospital implement the Babyleo TN500 IncuWarmer beds from Draeger

Dräger's new IncuWarmer Babyleo TN500 offers optimal thermoregulation in neonatal care

Going global. Scottish online medical specialist signs another international deal with Australian nurse college

Report describes clinical characteristics and outcomes of children hospitalized with COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News